168 related articles for article (PubMed ID: 30394384)
21. The Gut-Liver Axis in the Control of Energy Metabolism and Food Intake in Animals.
Ringseis R; Gessner DK; Eder K
Annu Rev Anim Biosci; 2020 Feb; 8():295-319. PubMed ID: 31689373
[TBL] [Abstract][Full Text] [Related]
22. Role of Gut Microbiota in Liver Disease.
Brenner DA; Paik YH; Schnabl B
J Clin Gastroenterol; 2015; 49 Suppl 1(0 1):S25-7. PubMed ID: 26447960
[TBL] [Abstract][Full Text] [Related]
23. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
24. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
[TBL] [Abstract][Full Text] [Related]
25. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation.
Guerville M; Boudry G
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G1-G15. PubMed ID: 27151941
[TBL] [Abstract][Full Text] [Related]
27. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats.
Bielinska K; Radkowski M; Grochowska M; Perlejewski K; Huc T; Jaworska K; Motooka D; Nakamura S; Ufnal M
Nutrition; 2018 Oct; 54():33-39. PubMed ID: 29705499
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota and probiotics in chronic liver diseases.
Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
[TBL] [Abstract][Full Text] [Related]
29. Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress.
Karl JP; Margolis LM; Madslien EH; Murphy NE; Castellani JW; Gundersen Y; Hoke AV; Levangie MW; Kumar R; Chakraborty N; Gautam A; Hammamieh R; Martini S; Montain SJ; Pasiakos SM
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G559-G571. PubMed ID: 28336545
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
[TBL] [Abstract][Full Text] [Related]
31. Gut-liver axis in alcoholic liver disease.
Szabo G
Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
[TBL] [Abstract][Full Text] [Related]
32. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
33. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
34. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
Lopetuso LR; Scaldaferri F; Bruno G; Petito V; Franceschi F; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2015; 19(6):1068-76. PubMed ID: 25855934
[TBL] [Abstract][Full Text] [Related]
35. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
36. High-fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers.
Gohir W; Kennedy KM; Wallace JG; Saoi M; Bellissimo CJ; Britz-McKibbin P; Petrik JJ; Surette MG; Sloboda DM
J Physiol; 2019 Jun; 597(12):3029-3051. PubMed ID: 31081119
[TBL] [Abstract][Full Text] [Related]
37. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
38. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
39. Influence of functional food components on gut health.
Wan MLY; Ling KH; El-Nezami H; Wang MF
Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
[TBL] [Abstract][Full Text] [Related]
40. Supplementation of a propionate-producing consortium improves markers of insulin resistance in an in vitro model of gut-liver axis.
El Hage R; Hernandez-Sanabria E; Calatayud Arroyo M; Van de Wiele T
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E742-E749. PubMed ID: 31935110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
